Stock Quote
E. I. du Pont de Nemours and Company (DD.N) (New York Stock Exchange)
| Name | Current Position | Compensation |
|---|---|---|
| Kullman, Ellen | Chairman of the Board, President, Chief Executive Officer | 4,443,470 |
| Fanandakis, Nicholas | Chief Financial Officer, Senior Vice President | -- |
| Keefer, Jeffrey | Executive Vice President - DuPont Finance | 4,286,210 |
Profile
Company Address
1007 Market Street
Wilmington DE 19898
P: +1302.7741000
F: +1302.7732631
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| 3M Company | $77.91 | +0.30 |
| Abbott Laboratories | $53.34 | -1.07 |
| Air Products & Chemicals, Inc. | $83.34 | +0.75 |
| DD.N | Industry | |
|---|---|---|
| P/E(TTM) | 47.50 | 4.64 |
| P/S(TTM) | 1.19 | 0.15 |
| ROI(TTM) | 2.53 | 0.05 |
| ROE(TTM) | 6.80 | 0.10 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 1.01 |
| EPS Est. (Current Year) | 2.01 |
| Total Revenue | $6,156.00M |
| Net Income | $414.00M |
| EPS | $0.45 |

